Moreover, inhibition of clonogenic survival and chemotaxis of PTEN-deficient PC cells required the combined use of p110β plus AKT2 inhibitors, whereas for PTEN-positive cells, p110α plus AKT1 inhibitors had the greater effect. The gene discussed is AKT1; the disease is pachyonychia congenita.